Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

August 01, 1996; Volume 278,Issue 2
  • You have access
    Regulation of corticotropin-releasing factor-binding protein expression in cultured rat astrocytes.
    D Maciejewski, P D Crowe, E B De Souza and D P Behan
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 455-461;
  • You have access
    The presynaptic alpha-2 autoreceptors in pig brain cortex are alpha-2A.
    A U Trendelenburg, N Limberger and K Starke
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 462-467;
  • You have access
    Angiotensin II-mediated activation of L-type calcium channels involves phosphatidylinositol hydrolysis-independent activation of protein kinase C in rat portal vein myocytes.
    N Macrez-Leprêtre, J L Morel and J Mironneau
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 468-475;
  • You have access
    Thrombin stimulates atrial natriuretic peptide secretion from rat cardiac atrium.
    L Klapper, S Nachshon, O Zamir and N Zamir
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 476-481;
  • You have access
    Modulation by cyclic AMP of beta adrenergic receptor-stimulated prostacyclin synthesis in rabbit ventricular myocytes.
    Y Ruan, H Kan and K U Malik
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 482-489;
  • You have access
    Role of extracellular dopamine in the initiation and long-term expression of behavioral sensitization to cocaine.
    C A Heidbreder, A C Thompson and T S Shippenberg
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 490-502;
  • You have access
    Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation.
    M D Nyby, M Sasaki, Y Ideguchi, H E Wynne, M T Hori, M E Berger, M S Golub, A S Brickman and M L Tuck
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 503-509;
  • You have access
    Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal.
    L L Devaud, R H Purdy, D A Finn and A L Morrow
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 510-517;
  • You have access
    Role of phospholipase C and phospholipase A2 in the nitric oxide-independent vasodilator effect of bradykinin in the rat perfused heart.
    D Fulton, J C McGiff and J Quilley
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 518-526;
  • You have access
    Functional characterization of alpha-1-adrenoceptor subtypes in the prostatic urethra and trigone of male rabbit.
    V Deplanne and A M Galzin
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 527-534;
  • You have access
    Vascular hyporesponsiveness in aorta from portal hypertensive rats: possible sites of involvement.
    Y T Huang, G F Wang, M C Yang, S P Chang, H C Lin and C Y Hong
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 535-541;
  • You have access
    Interactions between ethanol, endogenous adenosine and adenosine uptake in hippocampal brain slices.
    L Diao and T V Dunwiddie
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 542-546;
  • You have access
    Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
    J D Wagstaff, J W Gibb and G R Hanson
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 547-554;
  • You have access
    Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle.
    K Muraki, H Nakagawa, N Nagano, S Henmi, H Kawasumi, T Nakanishi, K Imaizumi, T Tokuno, K Atsuki, Y Imaizumi and M Watanabe
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 555-563;
  • You have access
    Carrier-mediated active transport of BQ-123, a peptidic endothelin antagonist, into rat hepatocytes.
    T Nakamura, A Hisaka, Y Sawasaki, Y Suzuki, T Fukami, K Ishikawa, M Yano and Y Sugiyama
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 564-572;
  • You have access
    Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
    W Gonzalez, F Beslot, I Laboulandine, M C Fournié-Zaluski, B P Roques and J B Michel
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 573-581;
  • You have access
    Mechanism mediating basolateral transport of 2,4-dichlorophenoxyacetic acid in rat kidney.
    A R Villalobos, C A Dunnick and J B Pritchard
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 582-589;
  • You have access
    Comparative distribution of quinolone antibiotics in cerebrospinal fluid and brain in rats and dogs.
    T Ooie, H Suzuki, T Terasaki and Y Sugiyama
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 590-596;
  • You have access
    Mechanism of alpha-2 adrenergic modulation of canine cardiac Purkinje action potential.
    H C Lee, J J Cai, D O Arnar, E F Shibata and J B Martins
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 597-606;
  • You have access
    The endothelin receptor is a major determinant for the nonlinear tissue distribution of the endothelin antagonist BQ-123.
    H C Shin, Y Kato, Y Shitara, T Yamada, T Nakamura, A Hisaka and Y Sugiyama
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 607-613;
  • You have access
    Effect of vinconate, an indolonaphthyridine derivative, on dopamine and serotonin concentrations in dialysate from the striatum of freely moving rats: brain microdialysis studies.
    T Iino, M Katsura and K Kuriyama
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 614-619;
  • You have access
    gamma-Aminobutyric acidA receptors and spinally mediated antinociception in rats.
    R Nadeson, Z Guo, V Porter, J P Gent and C S Goodchild
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 620-626;
  • You have access
    Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and synaptic transmission in hippocampus.
    A Arai, M Kessler, G Rogers and G Lynch
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 627-638;
  • You have access
    Simultaneous measurement of cyclopentyladenosine-induced contraction and intracellular calcium in bronchial rings from allergic rabbits and it's antagonism.
    S Ali, W J Metzger and S J Mustafa
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 639-644;
  • You have access
    Phospholipase D activity regulates the binding of leukotriene B4 to human polymorphonuclear leukocytes.
    D Kiel and S J Feinmark
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 645-653;
  • You have access
    Neurokinetic and myokinetic effects of the peptide xenin on the motility of the small and large intestine of guinea pig.
    G E Feurle, A Klein, G Hamscher, J W Metzger and J A Schuurkes
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 654-661;
  • You have access
    Differential effects of muscarinic receptor agonists and phorbol ester on muscarinic and D2-dopamine release-modulatory receptors.
    I S Hoffmann, R K Talmaciu, R Aquino and L X Cubeddu
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 662-668;
  • You have access
    Block of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by polyamines and polyamine toxins.
    M S Washburn and R Dingledine
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 669-678;
  • You have access
    Electrophysiological effects of N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl) cyclohexane carboxamide (WAY 100635) on dorsal raphe serotonergic neurons and CA1 hippocampal pyramidal cells in vitro.
    R Corradetti, E Le Poul, N Laaris, M Hamon and L Lanfumey
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 679-688;
  • You have access
    Morphine-induced alterations in antibody levels: receptor and immune mechanisms.
    L L Lockwood, L H Silbert, M R Fleshner, C McNeal, L R Watkins, M L Laudenslager, K C Rice, R J Weber and S F Maier
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 689-696;
  • You have access
    Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats.
    F J van der Staay, V C Hinz and B H Schmidt
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 697-708;
  • You have access
    Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats.
    J L Valentine, M Mayersohn, W D Wessinger, L W Arnold and S M Owens
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 709-716;
  • You have access
    Antiphencyclidine monoclonal antibody therapy significantly changes phencyclidine concentrations in brain and other tissues in rats.
    J L Valentine and S M Owens
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 717-724;
  • You have access
    Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission.
    W H Pan, J C Sung and S M Fuh
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 725-731;
  • You have access
    Pharmacologic characteristics of potentiation of 5-HT3 receptors by alcohols and diethyl ether in NCB-20 neuroblastoma cells.
    Q Zhou and D M Lovinger
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 732-740;
  • You have access
    A nitric oxide donor reverses myocardial injury in rabbits with acute hypercholesterolemia.
    S Hoshida, N Yamashita, J Igarashi, M Nishida, M Hori, T Kuzuya and M Tada
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 741-746;
  • You have access
    Human brain cholecystokinin: release of cholecystokinin-like immunoreactivity (CCK-LI) from isolated cortical nerve endings and its modulation through GABA(B) receptors.
    M Raiteri, G Bonanno, P Paudice, P Cavazzani and G Schmid
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 747-751;
  • You have access
    WAY-100635, a potent and selective 5-hydroxytryptamine1A antagonist, increases serotonergic neuronal activity in behaving cats: comparison with (S)-WAY-100135.
    C A Fornal, C W Metzler, R A Gallegos, S C Veasey, A C McCreary and B L Jacobs
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 752-762;
  • You have access
    Mechanisms of plumbagin action on guinea pig isolated atria.
    M Floreani, A Forlin, L Pandolfo, M Petrone and S Bellin
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 763-770;
  • You have access
    Effect of quercitrin on acute and chronic experimental colitis in the rat.
    F Sánchez de Medina, J Gálvez, J A Romero and A Zarzuelo
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 771-779;
  • You have access
    Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model.
    H Kawai, S Yuki, J Sugimoto and Y Tamao
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 780-785;
  • You have access
    Mechanism of stereoselective serum binding of ketoprofen after hemodialysis.
    T Sakai, T Maruyama, H Imamura, H Shimada and M Otagiri
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 786-792;
  • You have access
    Role of cyclic GMP-inhibitable phosphodiesterase and nitric oxide in the beta adrenoceptor control of renin secretion.
    T Chiu and I A Reid
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 793-799;
  • You have access
    Agonist synergism in airway smooth muscle contraction.
    W T Gerthoffer
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 800-807;
  • You have access
    Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.
    S D Hess, L P Daggett, J Crona, C Deal, C C Lu, A Urrutia, L Chavez-Noriega, S B Ellis, E C Johnson and G Veliçelebi
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 808-816;
  • You have access
    Mechanisms of nonlinear pharmacokinetics of mibefradil in chronically instrumented dogs.
    A Skerjanec, S Tawfik and Y K Tam
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 817-825;
  • You have access
    Ca(++)-dependence of caffeine modulation of the rate-force relation in canine cardiac Purkinje fibers.
    H Satoh and M Vassalle
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 826-835;
  • You have access
    Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
    K J Schuh, S L Walsh, G E Bigelow, K L Preston and M L Stitzer
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 836-846;
  • You have access
    Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways.
    L M Renzetti, P M Paciorek, S A Tannu, N C Rinaldi, J E Tocker, M A Wasserman and P R Gater
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 847-853;
  • You have access
    Use of chloride blockers: a novel approach for cardioprotection against ischemia-reperfusion damage.
    H Tanaka, S Matsui, T Kawanishi and K Shigenobu
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 854-861;
  • You have access
    Prejunctional alpha adrenoceptor desensitization in rat heart after chronic epinephrine treatment.
    S Apparsundaram and D C Eikenburg
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 862-870;
  • You have access
    Characterization of two cloned human CB1 cannabinoid receptor isoforms.
    M Rinaldi-Carmona, B Calandra, D Shire, M Bouaboula, D Oustric, F Barth, P Casellas, P Ferrara and G Le Fur
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 871-878;
  • You have access
    Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys.
    S S Negus, N K Mello, X Lamas and J H Mendelson
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 879-890;
  • You have access
    D-cycloserine, a partial agonist at the glycine site coupled to N-methyl-D-aspartate receptors, improves visual recognition memory in rhesus monkeys.
    N Matsuoka and T G Aigner
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 891-897;
  • You have access
    Novel benzodioxan derivative, 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl) amino]propoxy]-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models.
    M Abe, R Tabata, K Saito, T Matsuda, A Baba and M Egawa
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 898-905;
  • You have access
    Chronic in vivo and in vitro effects of amiodarone on guinea pig hearts.
    E A Sosunov, E P Anyukhovsky and M R Rosen
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 906-912;
  • You have access
    Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.
    A M Szczepanik, L R Brougham, J E Roehr, P G Conway, D B Ellis and C A Wilmot
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 913-920;
  • You have access
    Ovine prolactin increases hepatic UDP-glucuronosyltransferase activity in ovariectomized rats.
    M G Luquita, V A Catania, E J Sánchez-Pozzi and A D Mottino
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 921-925;
  • You have access
    Immunomodulator OM 163-induced reversal of tumor-mediated immunosuppression and downregulation of TGF-beta 1 in vivo.
    P Lagadec, S Reveneau, P Lejeune, D Pinard, T Borman, J Bauer and J F Jeannin
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 926-933;
  • You have access
    Chloramphenicol and the inflammatory response in the rat. Upregulation of the gene for T2-kininogen in liver.
    P Raymond, H Wang, C Blais, A Décarie, A Adam and R Morais
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 934-940;
  • You have access
    A comparison of the effects of glial cell line-derived neurotrophic factor on spinal cord and cortex cerebri grafts.
    K Trok, S Almström and L Olson
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 941-949;
  • You have access
    Leukotriene B4 modulates in vivo expression of delayed-type hypersensitivity by a receptor-mediated mechanism: regulation by lipoxin A4.
    Z Feng, H P Godfrey, S Mandy, S Strudwick, K T Lin, E Heilman and P Y Wong
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 950-956;
  • You have access
    Escherichia coli expression and substrate specificities of canine cytochrome P450 3A12 and rabbit cytochrome P450 3A6.
    S L Born, D J Fraser, G R Harlow and J R Halpert
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 957-963;
  • You have access
    Inhibition by zinc protoporphyrin-IX of vasoactive intestinal peptide-induced relaxations of guinea pig isolated trachea.
    B J Undem, J L Ellis, S Meeker, A Fischer and B J Canning
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 964-970;
  • You have access
    Pharmacokinetics and tissue disposition of a chimeric oligodeoxynucleoside phosphorothioate in rats after intravenous administration.
    R Zhang, R P Iyer, D Yu, W Tan, X Zhang, Z Lu, H Zhao and S Agrawal
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 971-979;
  • You have access
    Morphine suppresses the alloantigen-driven CTL response in a dose-dependent and naltrexone reversible manner.
    M Scott and D J Carr
    Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 980-988;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 278, Issue 2
1 Aug 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics